Dare Bioscience Inc (NAS:DARE)
$ 3.2711 -0.1 (-2.98%) Market Cap: 27.96 Mil Enterprise Value: 13.07 Mil PE Ratio: 0.21 PB Ratio: 10.45 GF Score: 34/100

Q2 2022 Dare Bioscience Inc Earnings Call Transcript

Aug 09, 2022 / 08:30PM GMT
Release Date Price: $14.64 (-2.40%)
Operator

Good afternoon. My name is Joanne, and I will be your conference operator today. At this time, I would like to welcome everyone to the Daré Bioscience, Inc. Q2 2022 Conference Call. (Operator Instructions) After the speaker's remarks, there will be a question-and-answer session. (Operator Instructions)

Ms. Johnson, you may begin your conference.

Sabrina Martucci Johnson;Bioscience
DarÃ;Inc. - President, CEO, Secretary & Director

© -

Wonderful. Thank you. Good afternoon, and welcome to our Second Quarter 2022 Financial Results and Business Update Call for Dare Bioscience. Our plan today is to review our second quarter results, discuss development since our last call in May and use the time to review our business strategy and highlight our objectives and milestones anticipated for the rest of 2022.

Before we begin, I would like to remind you that today's discussion will include forward-looking statements within the meaning of the federal securities laws, which are made pursuant to the safe harbor provisions of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot